Nestlé has launched a science-based growth milk solution containing human milk oligosaccharides (HMOs) in mainland China under the Wyeth Illuma brand. This product, manufactured at Nestlé’s Suzhou factory, marks the first HMO launch in China approved by the National Health Commission. HMOs are crucial for intestinal and immune health as well as cognitive development in infants, and within the scope of Nestlé’s global leadership, plans are underway to expand the HMO offering in China.